Advertisement Rising Pharmaceuticals to launch generic version of Gris-PEG(R) - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Rising Pharmaceuticals to launch generic version of Gris-PEG(R)

Rising Pharmaceuticals will unveil the first generic version of the Ultramicrosize Griseofulvin tablets USP 25mg and 250mg strengths, which are an FDA approved generic version of PEDiNOL Pharmacal's Gris-PEG(R).

Used to treat fungus infections, the Ultramicrosize Griseofulvin tablets had sales nearly of $16.7m for the twelve months ended 30 June 2012 in the US market, according to IMS Health data.

Rising Pharmaceuticals is a finished dosage form generics subsidiary of ACETO Corporation, which markets, sells and distributes products for human health, pharmaceutical ingredients and performance chemicals.